SimilarityLab: Molecular Similarity for SAR Exploration and Target Prediction on the Web
暂无分享,去创建一个
[1] R. M. Owen,et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies , 2015, Nature Reviews Drug Discovery.
[2] Kun-Yi Hsin,et al. EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities , 2010, Nucleic Acids Res..
[3] Jürgen Bajorath,et al. Evolving Concept of Activity Cliffs , 2019, ACS omega.
[4] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[5] Charlotte M. Deane,et al. Freely Available Conformer Generation Methods: How Good Are They? , 2012, J. Chem. Inf. Model..
[6] Jürgen Bajorath,et al. Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.
[7] Tom L. Blundell,et al. USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints , 2012, Journal of Cheminformatics.
[8] Gisbert Schneider,et al. Scaffold‐Hopping: How Far Can You Jump? , 2006 .
[9] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[10] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[11] Jürgen Bajorath,et al. Representation and identification of activity cliffs , 2017, Expert opinion on drug discovery.
[12] A. Aronov,et al. Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications , 2017, Nature Reviews Drug Discovery.
[13] Xi Jin,et al. Kekule.js: An Open Source JavaScript Chemoinformatics Toolkit , 2016, J. Chem. Inf. Model..
[14] J. Bajorath,et al. Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.
[15] M. Stahl,et al. Scaffold hopping. , 2004, Drug discovery today. Technologies.
[16] E. Perl. Causalgia, pathological pain, and adrenergic receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] Rajarshi Guha,et al. Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..
[18] W. Tong,et al. Quantitative structure‐activity relationship methods: Perspectives on drug discovery and toxicology , 2003, Environmental toxicology and chemistry.
[19] Kwong-Sak Leung,et al. USR-VS: a web server for large-scale prospective virtual screening using ultrafast shape recognition techniques , 2016, Nucleic Acids Res..
[20] Douglas R. Houston,et al. UFSRAT: Ultra-Fast Shape Recognition with Atom Types –The Discovery of Novel Bioactive Small Molecular Scaffolds for FKBP12 and 11βHSD1 , 2015, PloS one.
[21] Jean-Louis Reymond,et al. SmilesDrawer: Parsing and Drawing SMILES-Encoded Molecular Structures Using Client-Side JavaScript , 2018, J. Chem. Inf. Model..
[22] A. Hopfinger,et al. Methods for applying the quantitative structure-activity relationship paradigm. , 2004, Methods in molecular biology.